Literature DB >> 1375344

Brief report: treatment of chronic inflammatory bowel disease in glycogen storage disease type Ib with colony-stimulating factors.

T F Roe1, T D Coates, D W Thomas, J H Miller, V Gilsanz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1375344     DOI： 10.1056/NEJM199206183262504

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  21 in total

Review 1.  Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease.

Authors:  J R Korzenik; B K Dieckgraefe
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

2.  Normoglycemia alone is insufficient to prevent long-term complications of hepatocellular adenoma in glycogen storage disease type Ib mice.

Authors:  Wai Han Yiu; Chi-Jiunn Pan; Paul A Mead; Matthew F Starost; Brian C Mansfield; Janice Y Chou
Journal:  J Hepatol       Date:  2009-02-05       Impact factor: 25.083

3.  The gene for glycogen-storage disease type 1b maps to chromosome 11q23.

Authors:  B Annabi; H Hiraiwa; B C Mansfield; K J Lei; T Ubagai; M H Polymeropoulos; S W Moses; R Parvari; E Hershkovitz; H Mandel; M Fryman; J Y Chou
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

4.  Breakdown of tolerance to the intestinal bacterial flora in inflammatory bowel disease (IBD)

Authors:  T T MacDonald
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

5.  Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor.

Authors:  Saskia B Wortmann; Johan L K Van Hove; Terry G J Derks; Nathalie Chevalier; Vijaya Knight; Andreas Koller; Esmee Oussoren; Johannes A Mayr; Francjan J van Spronsen; Florian B Lagler; Sommer Gaughan; Emile Van Schaftingen; Maria Veiga-da-Cunha
Journal:  Blood       Date:  2020-08-27       Impact factor: 22.113

6.  Neutropenia in glycogen storage disease Ib: outcomes for patients treated with granulocyte colony-stimulating factor.

Authors:  David C Dale; Audrey Anna Bolyard; Tracy Marrero; Merideth L Kelley; Vahagn Makaryan; Emily Tran; Jamie Leung; Laurence A Boxer; Priya S Kishnani; Stephanie Austin; Corbinian Wanner; Iris A Ferrecchia; Dina Khalaf; Dawn Maze; Joanne Kurtzberg; Cornelia Zeidler; Karl Welte; David A Weinstein
Journal:  Curr Opin Hematol       Date:  2019-01       Impact factor: 3.284

7.  Intestinal function in glycogen storage disease type I.

Authors:  G Visser; J P Rake; F T M Kokke; P G J Nikkels; P J J Sauer; G P A Smit
Journal:  J Inherit Metab Dis       Date:  2002-08       Impact factor: 4.982

Review 8.  Growth factors as treatment for inflammatory bowel disease: a concise review of the evidence toward their potential clinical utility.

Authors:  Josué Barahona-Garrido; Jorge Hernández-Calleros; Ignacio García-Juárez; Jesús K Yamamoto-Furusho
Journal:  Saudi J Gastroenterol       Date:  2009 Jul-Sep       Impact factor: 2.485

9.  A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity.

Authors:  Juan D Matute; Andres A Arias; Nicola A M Wright; Iwona Wrobel; Christopher C M Waterhouse; Xing Jun Li; Christophe C Marchal; Natalie D Stull; David B Lewis; MacGregor Steele; James D Kellner; Weiming Yu; Samy O Meroueh; William M Nauseef; Mary C Dinauer
Journal:  Blood       Date:  2009-08-19       Impact factor: 22.113

10.  New treatment options in the management of IBD - focus on colony stimulating factors.

Authors:  Josué Barahona-Garrido; Jesús K Yamamoto-Furusho
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.